Prot #CTH-300: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy, Safety and Tolerability of APL-130277 in Levodopa Responsive Patients with Parkinson's Disease Complicated by Motor Fluctuations (“OFF” E

  • Zadikoff, Cindy (PD/PI)

Project: Research project

Project Details

Effective start/end date9/28/159/28/18


  • INC Research, LLC (Protocol # CTH-300)
  • Cynapsus Therapeutics Inc. (Protocol # CTH-300)